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Twist-mediated Epithelial-
mesenchymal Transition Promotes 
Breast Tumor Cell Invasion via 
Inhibition of Hippo Pathway
Yifan Wang1,4,*, Jingyi Liu2,3,4,*, Xuhua Ying1, Pengnian Charles Lin3 & Binhua P. Zhou4
Twist is a key transcription factor for Epithelial-mesenchymal transition (EMT), which is a cellular de-
differentiation program that promotes invasion and metastasis, confers tumor cells with cancer stem 
cell (CSC)-like characteristics, and increases therapeutic resistance. However, the mechanisms that 
facilitate the functions of Twist remain unclear. Here we report that Twist overexpression increased 
expression of PAR1, an upstream regulator of the Hippo pathway; PAR1 promotes invasion, migration, 
and CSC-like properties in breast cancer by activating the transcriptional co-activator TAZ. Our study 
indicates that Hippo pathway inhibition is required for the increased migratory and invasiveness ability 
of breast cancer cells in Twist-mediated EMT.
Breast cancer is the most common cancer in women worldwide, and approximately 90% of breast cancer deaths 
are the result of metastasis. Metastasis is the process by which tumor cells detach from a primary tumor and 
migrate to nearby blood vessels or the lymph system, and are thereby able to spread to other organs in the host1. 
During metastasis, tumor cells acquire a highly motile phenotype through a de-differentiation program known 
as epithelial to mesenchymal transition (EMT). EMT, a phenomenon traditionally associated with embryonic 
development, is now accepted as a central mechanism that induces invasion and metastasis of tumors2,3. As part 
of the EMT process, epithelial cells lose their apical-basal polarity and intercellular adhesive property; in proxy, 
the cells gain mesenchymal properties, including fibroblast-like morphology and increased motility, all of which 
favor invasion and dissemination. EMT also bestows tumor cells with cancer stem cell (CSC)-like characteristics, 
and an associated therapeutic resistance.
Breast cancer is a heterogeneous disease in terms of tumor histology, clinical presentation, and response to 
therapy. There are four major subtypes based on gene expression profiling: luminal A, luminal B, ErbB2, and 
basal like. Breast cancer undergoes EMT and show a basal-like phenotype, suggesting that EMT occurs within 
a specific genetic context in breast cancers4. A better understanding of the mechanisms that support the EMT 
program in breast cancer is crucial in order to develop new therapeutic strategies. A hallmark of EMT is the loss 
of E-cadherin expression3. Several transcription factors have been implicated in the transcriptional repression of 
E-cadherin and function as molecular switches for the EMT program3,5,6. Twist and Snail are two transcriptional 
factors that are crucial to EMT activation, and cooperate to support development of full invasive and metastatic 
capacity. For example, during the mesoderm formation in Drosophila, twist and snail function as positive and 
negative regulators, respectively; Twist acts as a transcriptional activator to induce mesodermal gene expression, 
whereas Snail serves as a transcriptional suppressor to prevent expression of genes that belong to ectoderm7. 
Similar cooperative activities suggest that Twist and Snail work synergistically to induce EMT8.
Protease-activated receptors (PARs) are members of a subfamily of G protein-coupled receptors that play 
critical roles in development, inflammation and angiogenesis, and cancer. PARs contribute to tumor cell motility 
and metastasis9. PAR1, also known as the coagulation factor II (thrombin) receptor, is a protein encoded by the 
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F2R gene in humans. PAR1 is thought to be involved in the invasive and metastatic processes of several types of 
cancer, including breast, colon, lung, pancreas and prostate cancers10–13. Recent research shows that the PARs 
are upstream signals of Hippo pathway14. The Hippo signaling pathway, initially discovered by genetic studies 
in Drosophila as a regulator of organ size, plays a crucial role in tissue growth, and in tumorigenesis15. PAR1 acts 
through the G12/13 and Rho GTPase to inhibit the Hippo pathway kinases Lats1/2; this kinase activates down-
stream signaling of YAP/TAZ by decreasing its phosphorylation and increasing nuclear localization14. Therefore, 
Hippo inhibition and the associated YAP/TAZ activation function as a key downstream signaling branch of PAR1 
activation. However, the proteases responsible for activating the pro-invasive functions of PAR1 are, to date, not 
identified.
In this study, we found that the expression of Twist induced EMT in mammary epithelial cells and lumi-
nal breast cancer cells, and that PAR1 and TAZ were activated in these Twist-overexpressing transfectants. 
Knockdown of TAZ expression significantly decreased the expression of connective tissue growth factor (CTGF) 
and suppressed the invasive properties mediated by Twist. Together, our results indicate that the activation of 
PAR1 and the inhibition of Hippo pathway are required for the Twist-induced EMT. Therefore, our study not only 
reveals a critical mechanism underlying metastasis but also has implications for the development of therapeutic 
strategies for breast cancer.
Results
Overexpression of Snail or Twist induces EMT. To determine the role of Snail and Twist in EMT, we 
expressed Snail or Twist in immortalized human mammary epithelial cells (HMLE). Expression of Snail or Twist 
induced morphologic changes in HMLE cells, from a cobble-stone-like epithelial appearance to a spindle-shaped 
fibroblastic-like phenotype; these cells became elongated in shape and disassociated from their neighboring cells 
(Fig. 1A). Immunofluorescence staining showed downregulation of the epithelial marker E-cadherin, and upreg-
ulation of the mesenchymal marker Vimentin. Western blot analysis confirmed these results (Fig. 1B). We also 
expressed Snail or Twist in two luminal breast cancer cell lines, T47D and MCF7, that contain little endogenous 
Snail and Twist. Expression of Snail or Twist induced EMT in these cells, and converted the morphology of 
luminal cells to a basal-like phenotype (Fig. 2A). In addition, we found downregulation of the luminal epithelial 
markers E-cadherin and ERα , and the upregulation of the mesenchymal marker N-cadherin by immunofluores-
cence and western blot analysis (Fig. 2A,B). Long term (over 10 days) expression of Snail in T47D and MCF7 cells 
led to apoptosis in both cell lines (Table 1), and expression of Twist in MCF7 cells also led to apoptosis in this cell 
line. Interestingly, overexpression of Twist in T47D cells did not result in apoptosis, but led to the formation of a 
stable cell line with morphologic changes typical of EMT (Table 1). The mRNA levels of E-cadherin and ERα were 
dramatically decreased in this transformed cell line (Fig. 2C).
Twist expands the stem cell population. To investigate whether Twist-expression affects proliferation 
of breast cancer cells, we measured cell growth of T47D-Twist cells by cell counting. T47D-Twist cells did not 
demonstrate a significant growth difference compared with the vector control cells over the 96-hour interval 
examined (Fig. 3A). We also examined tumorsphere formation of these cells, which is based on the unique prop-
erty of stem/progenitor cells to survive and grow in serum-free suspension. Although both T47D-vector and 
T47D-Twist cell types did form tumorspheres, the size and density of tumorspheres formed by T47D-Twist cells 
were lightly smaller than those formed by vector control cells under normoxic conditions. Under hypoxic condi-
tions, tumorspheres were sparse in vector control cells. Surprisingly, the size and density of tumorsphere formed 
by T47D-Twist cells were much bigger than that of control cells (Fig. 3B). These results suggest that expression 
of Twist promotes induction of CSC-like properties and their growth in T47D cells under hypoxic conditions.
Twist promotes cell migration and invasion. To investigate the migratory and invasive capabilities 
mediated by Twist, we performed an in vitro wound healing assay, which is commonly used to assess the effects 
of exogenous gene expression on the migration of individual cells. Closure of the scratch wound required signifi-
cantly less time in T47D-Twist cells than in vector control cells (Fig. 4A). Statistical analysis indicated that migra-
tion activity of T47D-Twist cells was about 3-fold higher than that of vector control cells (Fig. 4A). We also used 
Matrigel-coated Boyden chambers to assess cell invasiveness; the invasion capacity of T47D-Twist cells increased 
14-fold compared with that of vector control cells (Fig. 4B).
Twist induces PAR1 activation and Hippo inhibition. To understand the molecular mechanisms 
associated with Twist-induced EMT, we performed cDNA microarray analysis of HMLE and T47D cells that 
had undergone Twist-mediated EMT (Figs 1A and 2A). The mRNA of two PARs family genes, PAR1 (F2R) and 
PAR3 (F2RL2), were significantly elevated in both cell lines. These results were confirmed by qRT-PCR (Fig. 5A). 
Recently, these PAR proteins were identified as upstream regulators of the Hippo pathway, and play a crucial role 
in breast cancer invasion and metastasis. These data suggest that Twist regulates the Hippo pathway by upregu-
lating PAR expression.
Next, we investigated whether Twist expression suppresses the Hippo pathway by examing the expression of 
TAZ in T47D-Twist cells and the corresponding control vector cells. Since PAR1 inhibits the Lats1/2 kinases, 
we would expect that a Twist-mediated increase in PAR1 expression would decrease TAZ phosphorylation and 
increase TAZ activity. We found that TAZ was activated in T47D-Twist cells, and that the level of phosphorylated 
TAZ was significantly reduced (Fig. 5B). Consistent with this, the expression level of CTGF, a downstream tran-
scriptional target of TAZ, was increased (Fig. 5B). These results support the idea that Twist suppresses the Hippo 
pathway by upregulating the PAR1 signaling.
If TAZ activation is crucial for the Twist-mediated EMT, depletion of TAZ should reverse the changes induced 
by Twist. To test this possibility, we employed a luciferase reporter assay to determine if TAZ is required for the 
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Twist-mediated activation of CTGF promoter. We found that expression of Twist increased the promoter activity 
of CTGF, however, this effect was blocked by knocking down the expression of TAZ (Fig. 5C). Taken together, 
these results indicate that Twist expression activates TAZ, which leads to an increase in CTGF promoter transac-
tivation as measured by luciferase activity. To further confirm the effect of TAZ, we knocked down the expression 
of TAZ by siTAZ in T47D-Twist cells and control vector cells (Fig. 5D), and performed wound healing and inva-
sion analyses. We found that the migration induced by Twist in T47D cells was reduced from 3-fold to 1.3-fold 
(Fig. 6A), and that the invasion capability was reduced from 14-fold to 5-fold (Fig. 6B); these data indicate that 
Hippo pathway inhibition is required for the increased migratory and invasiveness in Twist-mediated EMT.
Discussion
Accumulating evidence indicates that EMT-associated transcription factors endow cells with malignant traits, 
such as invasion, migration and therapeutic resistance. In this study, we showed that the exogenous expression 
of Twist induced EMT not only in normal mammary epithelial cells HMLE, but also in the luminal breast cancer 
Figure 1. Overexpression of Snail or Twist induces EMT in HMLE cells. (A) Representative images 
show expression of E-cadherin and Vimentin in Snail- or Twist-expressing HMLE cells analyzed by 
immunofluorescent staining. Nuclei were visualized with DAPI staining (red). The morphologic changes 
associated with EMT are shown in the representative phase contrast images. Scale bars, 50 μm. (B) Expression 
of E-cadherin, N-cadherin and Vimentin in these cells was assessed by western blot analysis; actin served as a 
loading control.
www.nature.com/scientificreports/
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Figure 2. Overexpression of Snail or Twist induces EMT in T47D and MCF7 cells. (A) Representative 
images show expression of E-cadherin and ERα in Snail- or Twist-expressing T47D and MCF7 cells analyzed 
by immunofluorescent staining. Nuclei were visualized with DAPI staining (blue). The morphologic changes 
associated with EMT are shown in representative phase contrast images. Scale bars, 50 μm. (B) Expression of 
E-cadherin, N-cadherin and ERα in these cells was assessed by western blot analysis; actin served as a loading 
control. (C) Quantification of the relative mRNA levels of E-cadherin and ERα in Twist expressing T47D cells 
compared with vector-control cells using real-time PCR. Presented data are the mean ± SD from three separate 
experiments, with *and **indicate p < 0.01 in comparison with that of control.
www.nature.com/scientificreports/
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cells T47D. We established a T47D cell line stably expressing Twist, and this cell line displayed a mesenchymal 
cell phenotype.
Our study demonstrates that Twist-induced EMT in T47D cells is accompanied by functional effects, includ-
ing increased cell invasion, migration and CSC-like properties under hypoxic conditions. We also established that 
Twist activates PAR1 and PAR3 gene expressions. The PARs are a unique class of G-protein-coupled receptors 
that act as high-gain sensors of extracellular protease gradients, allowing cells to react to a proteolytic microen-
vironment10. PARs have been implicated in tumor progression. PAR1 is not expressed in normal breast epithelia 
but is upregulated in invasive breast carcinomas16. The invasive MDA-MB-231 breast cancer cell line express high 
levels of PAR117. In our study, activation of PAR1 in noninvasive T47D cells accompanied the acquisition of a 
mesenchymal phenotype and suppression of the Hippo pathway (Fig. 6C).
Major components of the Hippo pathway, including the MST1/2 and Lats1/2 kinases, are highly conserved 
and play an important role in control of mammalian organ size, cell proliferation, apoptosis, and stem cell dif-
ferentiation18. PARs regulate the Hippo pathway. Activation of PAR1 and other G protein coupled receptors that 
link to G12/13, trigger the activation of Rho GTPase, which works through the actin cytoskeleton to inhibit the 
Lats1/2 kinase and subsequently activates YAP/TAZ by decreasing its phosphorylation and increasing nuclear 
localization14. PAR3 was speculated to modulate PAR1 signaling by receptor dimerization. PAR3 had been 
reported functions as an important allosteric modulator of PAR1 signaling. PAR1 heterodimerization with PAR3 
alters the PAR1/Gα 13 binding conformation, enhancing Gα 13 signaling19. TAZ, a transducer of Hippo pathway, 
was reported to confer CSC-related traits on breast cancer cells, and was required to sustain self-renewal and 
tumor-initiation capacities in breast cancer stem cells20. We hypothesize that PAR1 overexpression induced by 
Twist could contribute to breast cancer cell progression by inhibiting Hippo pathway. In our study, we found that 
the expression level of TAZ was upregulated by Twist expression, while the phosphorylation level of TAZ was 
downregulated. Dephosphorylated TAZ functions as transcription coactivators for the TEAD family of tran-
scription factors to induce gene expression, thereby promoting cell growth, proliferation, and survival21–23. We 
found that the expression level of CTGF, a known TAZ target gene15,24, was increased in Twist-expressing T47D 
cells. The luciferase activity of the CTGF promoter was also enhanced. To further address the role of TAZ in the 
Twist regulated Hippo pathway, we knocked down the expression of TAZ, and found that clear reversion of lucif-
erase activity was observed by TAZ depletion in Twist-expressing T47D cells. Moreover, TAZ ablation suppressed 
migration and invasion capability as determined by the wound healing and invasion assays. These results imply 
that Twist activates TAZ in the Hippo pathway and that TAZ depletion inhibits Twist-induced cell migration and 
invasion.
In summary, we delineated the cross-talk between Twist-mediated EMT and the Hippo pathway in metastatic 
breast cancer. We showed that PAR1 was activated by Twist. The induction of PAR1 expression was critical for 
the Twist-mediated promotion of EMT and cell invasion and migration. Activated PAR1 signaling induced the 
expression of TAZ by suppressing Hippo pathway, and bestowed breast cancer cells with stem cell properties 
(Fig. 6C). Together, our experiments revealed a role for PAR1 in promoting EMT and invasive potential of breast 
cancer cells, suggesting that PAR1 might be a potential therapeutic target for EMT and metastasis of breast cancer.
Methods
Plasmids, siRNA, and Antibodies. Smart pool siRNA against TAZ was obtained from Dharmacon 
(Chicago, IL). Human Twist and Snail were amplified from a HeLa cDNA library and subcloned into pLenti6.3/V5. 
Antibodies for Vimentin and ERα were from Neomarkers (Fremont, CA). Antibodies for E-cadherin and TAZ 
were from BD Transduction Laboratories (San Jose, CA). Antibodies for Twist, YAP, p-YAP and CTGF were pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA). Snail and N-cadherin antibodies was purchased from 
Cell Signaling Technology (Danvers, MA) and Upstate (Charlottesville, VA), respectively.
Cell Culture. The MCF7 breast cancer cell line was grown in Dulbecco’s modified Eagle’s medium (DMEM)/F12 
supplemented with 10% fetal bovine serum (FBS). T47D cells were grown in RPMI1640 plus 10% FBS. HMLE 
was grown in DMEM/F-12 medium plus 10 ng/mL EGF, 10 μg/mL insulin and 0.5 μg/mL hydrocortisone. For 
establishing stable clones, transfected breast cell lines were selected with puromycin (1 μg/mL) for 4 wks.
Immunostaining and Immunoblotting. Experiments were performed as described previously25,26. For 
immunofluorescent staining, cells grown on chamber slides, were fixed with 4% paraformaldehyde, and incu-
bated overnight with primary antibodies. Secondary antibodies were Alexa Fluor 488 goat anti-mouse IgG 
(H + L), Alexa Fluor 568 goat anti-mouse IgG (H + L), or Alexa Fluor 568 goat anti-rat IgG (H + L) (Molecular 
Probe, Carlsbad, CA).
Cell lines EMT Apoptosis Survival
T47D control No No Yes
Snail Yes Yes No
Twist Yes No Yes
MCF7 control No No Yes
Snail Yes Yes No
Twist No Yes No
Table 1.  EMT, apoptosis and survival status in T47D and MCF7 cells with Snail/Twist overexpression.
www.nature.com/scientificreports/
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Quantitative Real-Time PCR. Total RNA was prepared using the RNeasy Mini kit (Qiagen) according to 
the manufacturer’s instructions. Specific quantitative real-time PCR experiments were performed using SYBR 
Green Power Master Mix following manufacturer’s protocol (Applied Biosystems).
Luciferase Reporter Assay. Luciferase reporter assays were performed as described previously25,27. Cells 
grown to 50% confluence in six-well plates were co-transfected with reporter gene constructs using Fugene 6 
(Roche, Indianapolis, IN). To normalize transfection efficiency, cells were also co-transfected with pTK-RL 
Figure 3. Overexpression of Twist induces CSC-like properties in T47D cells. (A) Graphic representation of 
cell growth rates by T47D cells stably expressing Twist or control vector. Cell counts were obtained daily over a 
4 day period. Presented data are the mean ± SD from two independent experiments with triplicate samples. NS 
stands for statistically non-significant. (B) Tumorsphere formation was assessed in T47D cells overexpressing 
Twist under normoxic or hypoxic conditions. Representative images of tumorspheres are shown in the right 
panel. Scale bars, 100 μm. Left panel, are graphic representations of tumorsphere number. Presented data are the 
percentage of control vector values, with mean ± SD of three separate experiments performed in duplicate.  
#p <  0.05 and *p <  0.01 when vector control cells compared with their Twist-expressing clones, respectively.
www.nature.com/scientificreports/
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(Renilla luciferase). Cell extracts, prepared 48 hrs after transfection, were assessed for luciferase activity using the 
Dual-Luciferase Reporter Assay System (Promega, Madison, WI). All experiments were performed three times 
in triplicate.
Invasion Assay. Invasion assays were performed in Boyden chambers coated with Matrigel as instructed by 
the manufacturer (BD Biosciences, San Jose, CA). Cancer cells were seeded on top of the Matrigel in the upper 
chamber, and the bottom chamber was filled with culture medium containing EGF (10 ng/mL) as the chemoat-
tractant. The invasive cancer cells, on the underside of the Boyden chamber membrane, were fixed with paraform-
aldehyde, stained with crystal violet and counted. All experiments were performed in triplicate.
Tumorsphere Assay. Tumorsphere assays were performed following the protocol previously described28,29. 
Briefly, cells were seeded in single-cell suspension in triplicate into ultra-low attachment 6-well plates (Corning) 
in DMEM/F12 medium supplemented with 20 ng/mL EGF, 5 mg/mL insulin, 0.5 mg/mL hydrocortisone and 
2% B27. After 1 to 2 wks incubation, the presence of spheres (3D multicellular structures greater than 40 μm in 
Figure 4. Overexpression of Twist enhances cell migration and invasion of T47D cells. (A) Graphic 
representation of the migratory capability of stably transfected T47D cells expressing either Twist or control 
vector assessed using a wound healing assay. A scratch (“wound”) was inflicted to a cell layer produced 48 
hours post-plating, and culture continued for an additional 24 hrs. Wound closures were photographed at 0 and 
24 hr. Presented data are the mean ± SD from three independent experiments, with *indicates p < 0.01 when 
comparing with control values. A representative experiment is shown in the right panel. Scale bars, 50 μm. 
(B) Graphic representation of the invasiveness of T47D cells stably expressing Twist or control vector using a 
modified Boyden Chamber invasion assay as described in the Materials and Methods. Presented data are the 
mean ± SD from three separate experiments, with *indicates p < 0.01 when comparing with control values. A 
representative experiment is shown in the right panel. Scale bars, 100 μm.
www.nature.com/scientificreports/
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Figure 5. Overexpression of Twist induces the activation of PAR1 signaling. (A) Graphic representation of 
the fold change in mRNA levels of Twist, F2R and F2RL2 in Twist-expressing T47D cells compared with control 
vector cells by real-time PCR. Presented data are the mean ± SD of three separate experiments, with *indicates 
p < 0.01 when comparing with control values. (B) Western blot analysis for p-TAZ, TAZ and CTGF expression 
in EMT-induced Twist-expressing T47D cells or T47D cells expressing control vector. Actin served as a loading 
control. (C) Effect of TAZ siRNA or NTC siRNA on CTGF promoter luciferase activity in Twist-overexpressing 
T47D cells and T47D cells expressing control vector. Assessments were made after 48 hours in culture. 
Presented data are mean ± SD of normalized luciferase activities determined from three separate experiments. 
*indicates p < 0.01 when control siRNA expressed in Twist-T47D cells compared with in vector control cells; 
and **indicates p < 0.01 when compared expression of TAZ siRNA and control siRNA in Twist-T47D cells.  
(D) Effect of TAZ siRNA on TAZ and Twist expression in EMT-induced Twist-expressing T47D cells and in 
T47D cells expressing control vector by western blot analysis. Actin served as a loading control.
www.nature.com/scientificreports/
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diameter) was assessed by inverted microscopy. Ten random fields for each cell lines were visualized; the number 
and size of spheres in the 10 fields were calculated as a percentage over that of parent cells.
Statistical Analysis. Experiments were repeated at least twice. Data are presented as mean ± SD. A Student’s 
t-test (two tailed) was used to compare two groups. p < 0.05 was considered statistically significant.
Figure 6. Knockdown of TAZ suppresses Twist-induced cell migration and invasion of T47D cells.  
(A) Effect of TAZ siRNA on cell migrating activity in Twist-overexpressing T47D cells and T47D cells 
expressing control vector using a wound healing assay. A scratch (“wound”) was inflicted to a cell layer 
produced 48 hours post-plating, and culture continued for an additional 24 hrs. Wound closures were 
photographed at 0 and 24 hr. Presented data are the mean ± SD from three independent experiments, with *and 
#indicating significant difference of p < 0.05 from control values. (B) Effect of TAZ siRNA on cell invasiveness 
in Twist-overexpressing T47D cells and T47D cells expressing control vector using a modified Boyden Chamber 
invasion assay as described in the Materials and Methods. Presented data are a graphic representation of the 
mean ± SD of percentage of invasive cells obtained from three separate experiments, with *and #indicating 
significant difference of p < 0.05 from control values. (C) Expression of Twist results in increased expression 
of PAR1, which promotes invasion, migration, and induces CSC-like properties in breast cancer cells by 
upregulating the expression of TAZ.
www.nature.com/scientificreports/
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